Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Motens 2mg tablets
0206020K0BBAAAA
|
Motens | Lacidipine | Cardiovascular System | 1,137 |
|
Olmesartan medoxomil 40mg / Amlodipine 5mg tablets
0205052ABAAABAB
|
Olmesartan medoxomil/amlodipine | Olmesartan medoxomil/amlodipine | Cardiovascular System | 1,137 |
|
HeelPro foot protector
21380000127
|
HeelPro foot protector | Low Friction Products | Appliances | 1,136 |
|
Sodium chloride 0.9% irrigation solution 1litre bottles
21160000050
|
Sodium chloride 0.9% irrigation solution 1litre bottles | Irrigation Solutions | Appliances | 1,135 |
|
Desmopressin 240microgram sublingual tablets sugar free
0605020E0AACACA
|
Desmopressin acetate | Desmopressin acetate | Endocrine System | 1,134 |
|
Epilim Chronosphere MR 750mg granules sachets
0408010W0BBARBY
|
Epilim | Sodium valproate | Central Nervous System | 1,134 |
|
NovoPen Echo hypod insulin inj pen reusable for 3ml cart 0.5 unit dial up/range 0.5-30 units red
21010900589
|
NovoPen Echo hypod insulin inj pen reusable for 3ml cart 0.5 unit dial up/range 0.5-30 units red | Other Appliances | Appliances | 1,133 |
|
Sastravi 100mg/25mg/200mg tablets (Accord Healthcare Ltd)
0409010X0BCAHAB
|
Sastravi | Levodopa/carbidopa/entacapone | Central Nervous System | 1,133 |
|
Acticoat Flex 3 dressing 10cm x 10cm square
20031900021
|
Acticoat Flex 3 dressing 10cm x 10cm square | Wound Management & Other Dressings | Dressings | 1,132 |
|
Provox Life Home HME filter cassette
20050600116
|
Provox Life Home HME filter cassette | Tracheostomy & Laryngectomy Appliances | Dressings | 1,131 |
|
Galantamine 20mg/5ml oral solution sugar free
0411000F0AAADAD
|
Galantamine | Galantamine | Central Nervous System | 1,129 |
|
Urea 10% lotion
1302010U0AAAMAM
|
Urea (Emollient) | Urea | Skin | 1,129 |
|
Qtern 5mg/10mg tablets
0601023AVBBAAAA
|
Qtern | Saxagliptin/dapagliflozin | Endocrine System | 1,127 |
|
Flupentixol 20mg/1ml solution for injection ampoules
0402020G0AAAAAA
|
Flupentixol decanoate | Flupentixol decanoate | Central Nervous System | 1,126 |
|
Nitrazepam 2.5mg/5ml oral suspension
0401010R0AAAAAA
|
Nitrazepam | Nitrazepam | Central Nervous System | 1,126 |
|
Omnitrope SurePal 5 5mg/1.5ml inj cartridges
0605010S0BHADBK
|
Omnitrope | Somatropin | Endocrine System | 1,126 |
|
Brava mouldable ring 48mm x 2mm
23851008514
|
Brava mouldable ring 48mm x 2mm | Skin Protectors | Stoma Appliances | 1,124 |
|
Methylphenidate 50mg modified-release capsules
0404000M0AAAZAZ
|
Methylphenidate hydrochloride | Methylphenidate hydrochloride | Central Nervous System | 1,124 |
|
Salts mouldable seals with aloe, thin 15-40mm
23854108553
|
Salts mouldable seals with aloe, thin 15-40mm | Skin Protectors | Stoma Appliances | 1,124 |
|
Seroquel 100mg tablets
0402010ABBBACAC
|
Seroquel | Quetiapine | Central Nervous System | 1,124 |
|
Activon Tulle gauze dressing 5cm x 5cm
20040200430
|
Activon Tulle gauze dressing 5cm x 5cm | Gauzes & Gauze Tissue | Dressings | 1,122 |
|
Crystacide 1% cream
1310050H0BBABAA
|
Crystacide | Hydrogen peroxide | Skin | 1,122 |
|
Foodlink Complete Compact powder 57g sachets chocolate
0913011F0BCACAD
|
Foodlink powder 2.3 - 2.4 kcal/ml milkshake lower volume | Powder 2.3 - 2.4 kcal/ml milkshake lower volume (0913011) | Nutrition and Blood | 1,122 |
|
Sulpiride 200mg/5ml oral solution sugar free
0402010U0AAAEAE
|
Sulpiride | Sulpiride | Central Nervous System | 1,122 |
|
Prosys sterile leg bag with non-flocked back and lever tap 500ml long
22500955015
|
Prosys sterile leg bag with non-flocked back and lever tap 500ml long | Leg Bags | Incontinence Appliances | 1,121 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.